3-10 October 200800
Tt
N-deal will Help Trigger Pharma, Biotech Innovations
The end of India's nuclear apartheid at the last Vienna meeting of the Nuclear Suppliers Group (NSG) and the conclusion of the controversial nuclear deal with the US could spell a new era for the country's biotechnology and pharmaceutical companies. The deal is expected to open up access to critical genetic products and bio-materials, besides the latest technology to deal with them.
     
Apollo Joins Hand with Merk to set up 200 Diabetes Clinics
One of the major healthcare groups in India Apollo Hospitals and MSD Pharmaceuticals, the Indian subsidiary of US drug giant Merk, have entered into a memorandum of understanding to set up 200 diabetes clinics across the country to provide a comprehensive diabetes management. The company has launched two diabetes management clinics in Hyderabad, India, on pilot basis and
Tt
     
Tt
NPPA Revises Prices
6 Bulk Drugs
The National Pharmaceutical Pricing Authority (NPPA) has cut prices of three bulk drugs, two of them by nearly 50 per cent, and increased prices of three other bulk drugs including human insulin. The prices of sulphamethoxazole, potassium penicillin, benzathine penicillin, salbutamol sulphate and human insulin were revised, to be made effective within 15 days from September 25.
     
NPPA's First Information Facilitation Centre Launched in Chennai
The new initiative of National Pharmaceutical Pricing Authority, 'NPPA-CIFG' was launched in Chennai by the Union minister of state for chemicals, fertilizers and mines B K Handique. This is the first Centre for Information Facilitation and Grievances (CIFG) inaugurated in the country with the motto of 'Affordable Medicines for All', a dream project of the National Pharmaceutical Pricing Authority (NPPA).
Tt
     
Tt
Rising MNC Offshore Tie-ups with Indian Pharma Firms to Reduce Costs
Indian companies, especially in the pharmaceutical sector, are motivated to build long-term sustainable relationships with their multinational counterparts for mutual benefit. Indian pharmaceutical companies, through their high quality - low cost production models, have bagged some impressive deals in contract manufacturing space in the last few years. The need for speed and access to new markets
     
Government Approves 10 Testing
Units for Ayurvedic Drugs
The Centre has approved the setting up of 10 common testing facilities for small and medium ayurvedic manufacturers across the country. The decision by Department of AYUSH, Union Ministry of Health, would facilitate testing, quality control and standardisation of ayurvedic drugs. "The department has approved setting up of ten projects (testing facilities) in Kerala,
Tt
     
Tt
Kerala Social Security
Mission - Launched in Kerala
In a major initiative for providing health facilities to poor sections of society, CPI-M-led LDF government in Kerala launched a programme titled "Kerala Social Security Mission' which included extending free treatment to children suffering from cancer. A total of Rs.65 crore has been earmarked for the Mission and out of this an amount of Rs.15 crore would be set apart for the treatment of children
     
Interrad Medical Receives USFDA Clearance SecurAcath(TM) PICC
Interrad Medical, Inc. a privately held medical device company, announced that it has received FDA 510(k) clearance of its SecurAcath(TM) PICC with Subcutaneous Securement System. Interrad Medical has developed a completely new and innovative method for catheter securement called SecurAcath. The SecurAcath System utilizes a small anchor that deploys in
Tt
     
Tt
Ablynx is Awarded Eur 1.8 Million Grant To Explore Novel Methods For Uses Of Nanobodies(R)
In a major initiative for providing health facilities to poor sections of society, CPI-M-led LDF government in Kerala launched a programme titled "Kerala Social Security Mission' which included extending free treatment to children suffering from cancer. A total of Rs.65 crore has been earmarked for the Mission and out of this an amount of Rs.15 crore would be set apart for the treatment of children
     
9th ASIA Oceania CONGRESS of NUCLEAR MEDICINE & BIOLOGY
Society of Nuclear Medicine India will host the 9th Congress of NUCLEAR MEDICINE & BIOLOGY on 31 Oct 2008 - 04 Nov 2008 at The Ashok Hotel, Diplomatic Enclave 50-B Chanakayapuri. The 21st Century promises emergence of newer paradigms at various interfaces of modern medicine in general and in Molecular Imagining in particular, keeping in view the exponential growth made in this exciting
Tt
     
Tt
Alteplase - Stroke Drug Cuts Damage Even After 3 Hours says Study
Doctors are given just three hours to administer the clot-busting drug alteplase to help stroke patients, but a study released shows the drug still does some good as long as 4-1/2 hours later. But researchers reporting in the New England Journal of Medicine warned that the new findings do not mean that doctors can take their time treating stroke symptoms. "You have to get it done right now,"
     
• Expect inflation to go down albeit slowly to 7% by March-end.
• Inflation to move from 4-6% to 6-8% band for the next few years.
• Oil cools to early-June levels – volatility to continue.
• Cereal prices to go down, great monsoons in north and east.
 
Contact: enquiry@newmediacomm.biz
New Media Communication Pvt Ltd,
New Media House, 1 Akbar Villa, Near Old State Bank,
Marol-Maroshi Road, Andheri (East), Mumbai 400 059. (INDIA)
Tel: +91-22-2925 5279/ 2920 1999
 
 
 
 
 
 
 
AWARENESS
Awareness : Breast Problems and Cancer
Breast cancer is the second common type of cancer which kill women in our contemporary world. Women in the United States occupy the top position as they succumb to breast cancer in thousands every year. Though less common than females, men also fall prey to this cancer.

Women have trouble in differentiating unusual discomforts in their breasts from the usual ones. It is natural for women to have achy, heavy or sore breasts around their menstrual date due to some hormonal changes. Lumps in the breasts of women are also common as they pass their 30's.

 
 
 
 
 
Our Pharmaquest Portal
 
 
Readers can contribute Articles, Reports, Case Studies, Success Stories, Advertorials besides formal Advertisements.
 
Disclaimer: Since India has no anti-spamming law, we follow the US directive passed in Bill.1618 Title III by the 105th US Congress, which states that mail cannot be considered spam if it contains contact information, which this mail does. This mail is not a Spam Mail. In case you do not wish to receive mails (unsubscribe), kindly send a mail to susheela@newmediacomm.biz